Paragon: FDA Must Work With Developers, Providers On Post-Market AI Surveillance

FDA, artificial intelligence developers and providers should collaborate on “federated standardized outcome data networks” that would allow stakeholders to keep AI data locally while aggregating key information into centralized databases, according to a new policy brief from the conservative think tank Paragon Health Institute. Such data networks would support post-market surveillance of health AI tools, a current focus of agencies, lawmakers and AI developers as emerging technologies enter the health care sector. “We argue that to increase the expediency at...